How to cite item

Atezolizumab plus platinum-based regimen and bevacizumab: is it time to consider immunotherapy in a concurrent approach for lung cancer?

   
@article{TCR25256,
	author = {Andrea Bianco and Susan F. M. Campbell},
	title = {Atezolizumab plus platinum-based regimen and bevacizumab: is it time to consider immunotherapy in a concurrent approach for lung cancer?},
	journal = {Translational Cancer Research},
	volume = {8},
	number = {Suppl 2},
	year = {2018},
	keywords = {},
	abstract = {Targeting adaptive immunity is a game changer for cancer treatment, revolutionizing lung cancer management. Chemotherapy has been the standard treatment for lung cancer (1-4) until recently when molecular targets including genes harbouring cancer-driving mutations and immune check-points have emerged as targets for new therapies (5-12). With the increasing relevance of ICIs, clinical research is required to define which combination regimens provide the greatest benefits in  lung cancer patients.},
	issn = {2219-6803},	url = {https://tcr.amegroups.org/article/view/25256}
}